James O. Wilson

Array ( [id] => 4174540 [patent_doc_number] => 06083930 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers' [patent_app_type] => 1 [patent_app_number] => 8/471990 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 22 [patent_no_of_words] => 13145 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083930.pdf [firstpage_image] =>[orig_patent_app_number] => 471990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661722 [patent_doc_number] => 05624909 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Derivatives of triterpenoid acids as inhibitors of cell-adhesion molecules ELAM-1 (e-selectin) and LECAM-1 (l-selectin)' [patent_app_type] => 1 [patent_app_number] => 8/468888 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16401 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624909.pdf [firstpage_image] =>[orig_patent_app_number] => 468888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3510006 [patent_doc_number] => 05587361 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-24 [patent_title] => 'Oligonucleotides having phosphorothioate linkages of high chiral purity' [patent_app_type] => 1 [patent_app_number] => 8/469851 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11793 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/587/05587361.pdf [firstpage_image] =>[orig_patent_app_number] => 469851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3625681 [patent_doc_number] => 05620963 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Oligonucleotides for modulating protein kinase C having phosphorothioate linkages of high chiral purity' [patent_app_type] => 1 [patent_app_number] => 8/468569 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11784 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/620/05620963.pdf [firstpage_image] =>[orig_patent_app_number] => 468569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4031541 [patent_doc_number] => 05994325 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers' [patent_app_type] => 1 [patent_app_number] => 8/470092 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 9 [patent_no_of_words] => 13444 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994325.pdf [firstpage_image] =>[orig_patent_app_number] => 470092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3539056 [patent_doc_number] => 05494912 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-27 [patent_title] => '9-purinyl phosphonic acid derivitives for treating gout' [patent_app_type] => 1 [patent_app_number] => 8/467497 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11412 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 259 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/494/05494912.pdf [firstpage_image] =>[orig_patent_app_number] => 467497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623771 [patent_doc_number] => 05607923 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-04 [patent_title] => 'Oligonucleotides for modulating cytomegalovirus having phosphorothioate linkages of high chiral purity' [patent_app_type] => 1 [patent_app_number] => 8/467597 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11782 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/607/05607923.pdf [firstpage_image] =>[orig_patent_app_number] => 467597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730987 [patent_doc_number] => 05635488 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Compounds having phosphorodithioate linkages of high chiral purity' [patent_app_type] => 1 [patent_app_number] => 8/470129 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11156 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635488.pdf [firstpage_image] =>[orig_patent_app_number] => 470129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3666502 [patent_doc_number] => 05599797 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => 'Oligonucleotides having phosphorothioate linkages of high chiral purity' [patent_app_type] => 1 [patent_app_number] => 8/471967 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11783 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599797.pdf [firstpage_image] =>[orig_patent_app_number] => 471967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695635 [patent_doc_number] => 05661134 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'Oligonucleotides for modulating Ha-ras or Ki-ras having phosphorothioate linkages of high chiral purity' [patent_app_type] => 1 [patent_app_number] => 8/471966 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11795 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/661/05661134.pdf [firstpage_image] =>[orig_patent_app_number] => 471966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3625692 [patent_doc_number] => 05608048 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-04 [patent_title] => 'd.sub.4 T polymorphic Form 1 process' [patent_app_type] => 1 [patent_app_number] => 8/465208 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5291 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/608/05608048.pdf [firstpage_image] =>[orig_patent_app_number] => 465208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3659078 [patent_doc_number] => 05627185 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Acyclovir derivatives as antiviral agents' [patent_app_type] => 1 [patent_app_number] => 8/465450 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4244 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/627/05627185.pdf [firstpage_image] =>[orig_patent_app_number] => 465450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3646657 [patent_doc_number] => 05637576 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Treatment of traveller\'s diarrhea' [patent_app_type] => 1 [patent_app_number] => 8/461625 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8789 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637576.pdf [firstpage_image] =>[orig_patent_app_number] => 461625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3658733 [patent_doc_number] => 05627163 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Treatment of traveller\'s diarrhea' [patent_app_type] => 1 [patent_app_number] => 8/461294 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8791 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/627/05627163.pdf [firstpage_image] =>[orig_patent_app_number] => 461294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3764649 [patent_doc_number] => 05852182 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Thiol-derivatized oligonucleosides' [patent_app_type] => 1 [patent_app_number] => 8/458396 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10733 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 225 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/852/05852182.pdf [firstpage_image] =>[orig_patent_app_number] => 458396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3553190 [patent_doc_number] => 05574021 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-12 [patent_title] => 'Methods of treatment using 2\',3\'-dideoxy-2\',2\'-difluoronucleosides' [patent_app_type] => 1 [patent_app_number] => 8/458110 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16171 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 227 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/574/05574021.pdf [firstpage_image] =>[orig_patent_app_number] => 458110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3850511 [patent_doc_number] => 05719273 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-17 [patent_title] => 'Palladium catalyzed nucleoside modifications methods using nucleophiles and carbon monoxide' [patent_app_type] => 1 [patent_app_number] => 8/458421 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10116 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/719/05719273.pdf [firstpage_image] =>[orig_patent_app_number] => 458421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3667004 [patent_doc_number] => 05668269 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => '3\'-(2\')-amimo- or thiol-modified, fluorescent dye-coupled nucleosides, nucleotides and oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/456734 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6249 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/668/05668269.pdf [firstpage_image] =>[orig_patent_app_number] => 456734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775187 [patent_doc_number] => 05817638 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Antiviral liponucleosides: treatment of hepatitis B' [patent_app_type] => 1 [patent_app_number] => 8/456537 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 11979 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817638.pdf [firstpage_image] =>[orig_patent_app_number] => 456537 [rel_patent_id] =>[rel_patent_doc_number] =>)